跳至主要内容
临床试验/NCT03394976
NCT03394976撤回不适用

Prospective Evaluation of a Rapid Diagnostic Test to Screen for Gambiense Human African Trypanosomiasis and Diagnose Plasmodium Falciparum Malaria

Foundation for Innovative New Diagnostics, Switzerland0 个研究点开始时间: 2022年1月31日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
主要终点
sensitivity of the HAT/malaria combo test for P. falciparum malaria in passive screening

研究概览

简要总结

A prototype rapid diagnostic test (RDT) to simultaneously screen for gambiense human African trypanosomiasis (HAT) and diagnose P. falciparum malaria (the "HAT/malaria combo") has recently been developed. The performance of this prototype has been evaluated in a retrospective study that showed that its diagnostic performance for HAT and malaria was equivalent to the performance of the SD BIOLINE HAT 2.0 and the SD BIOLINE Malaria Ag P.f tests, respectively.

The purpose of this study is to prospectively evaluate the performance of the test in settings where P. falciparum malaria is endemic, and which are either endemic or non-endemic for HAT. This will enable the assessment of the suitability of the HAT/malaria combo RDT as a diagnostic test for malaria, and a screening test for HAT in pre-elimination and post-elimination contexts, respectively.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
6 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age greater than or equal to 6 years
  • Provision of signed informed consent. For children (under the age of 18) provision of signed informed consent by a parent or legal guardian and an age appropriate assent.

排除标准

  • Severe anaemia preventing collection of a sample of venous blood
  • Severe medical condition preventing informed consent and trial participation (e.g. coma, cognitive impairment, etc.)
  • For HAT true negatives only: history of previous HAT infection

结局指标

主要结局

sensitivity of the HAT/malaria combo test for P. falciparum malaria in passive screening

时间窗: Enrolment

specificity of the HAT/malaria combo test for P. falciparum malaria in passive screening

时间窗: Enrolment

specificity of the SD BIOLINE Malaria Ag P.f test for P. falciparum malaria in passive screening

时间窗: Enrolment

specificity of the HAT/malaria combo test for gambiense HAT in passive screening

时间窗: Enrolment

specificity of the SD BIOLINE HAT 2.0 test for gambiense HAT in passive screening

时间窗: Enrolment

sensitivity of the SD BIOLINE Malaria Ag P.f test for P. falciparum malaria in passive screening

时间窗: Enrolment

次要结局

  • specificity of the HAT/malaria combo test for gambiense HAT in passive screening in a population living in a setting where HAT and animal trypanosomiasis are not endemic(Enrolment)
  • specificity of the HAT/malaria combo test for gambiense HAT in passive screening in a population living in a setting where HAT is endemic(Enrolment)
  • specificity of the SD BIOLINE HAT 2.0 test for gambiense HAT in passive screening in a population living in a setting where HAT and animal trypanosomiasis are not endemic(Enrolment)
  • specificity of the SD BIOLINE HAT 2.0 test for gambiense HAT in passive screening in a population living in a setting where HAT is endemic(Enrolment)

研究者

发起方
Foundation for Innovative New Diagnostics, Switzerland
申办方类型
Other
责任方
Sponsor

相似试验

Prospective Evaluation of an RDT to Screen for... | 临床试验